![Christopher Anzalone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Anzalone
Chief Executive Officer at
ARROWHEAD PHARMACEUTICALS, INC.
Net worth: 321 M $ as of 31/07/2026
Profile
Christopher Richard Anzalone is a businessperson who founded Benet Group LLC and Nanotope, Inc. and who has been the head of 5 different companies. Currently, he is President, Chief Executive Officer & Director at Arrowhead Pharmaceuticals, Inc. and Chairman & Chief Executive Officer of Calando Pharmaceuticals, Inc. (a subsidiary of Arrowhead Pharmaceuticals, Inc.). Dr. Anzalone is also on the board of 5 other companies. In his past career Dr. Anzalone was Chief Executive Officer for NanoInk, Inc., Partner at Galway Partners LLC, President, Chief Executive Officer & Director at Nanotope, Inc. and Chief Executive Officer at Benet Group LLC. Christopher Richard Anzalone received a doctorate from the University of California, Los Angeles and an undergraduate degree from Lawrence University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/01/2026 | 3,792,739 ( 2.69% ) | 321 M $ | 31/07/2026 |
Christopher Anzalone active positions
| Companies | Position | Start |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Chief Executive Officer | 01/12/2007 |
Ablaris Therapeutics, Inc. | Director/Board Member | - |
Tego Biosciences Corp. | Director/Board Member | - |
Arrowhead Madison, Inc. | Director/Board Member | - |
Former positions of Christopher Anzalone
| Companies | Position | End |
|---|---|---|
NanoInk, Inc.
 NanoInk, Inc. Industrial MachineryProducer Manufacturing Manufactures nanolithography tools and other nanoscale devices | President | 01/01/2004 |
Galway Partners LLC
 Galway Partners LLC Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | 01/01/2003 |
| KRONOS BIO, INC. | Director/Board Member | - |
| VIR BIOTECHNOLOGY, INC. | Director/Board Member | - |
Roche Madison, Inc.
 Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Provides gene transfer technologies to the pharmaceutical industry | Director/Board Member | - |
Training of Christopher Anzalone
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
NanoInk, Inc.
NanoInk, Inc. Industrial MachineryProducer Manufacturing Manufactures nanolithography tools and other nanoscale devices | Producer Manufacturing |
Calando Pharmaceuticals, Inc.
 Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Health Technology |
Nanotope, Inc.
 Nanotope, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lawrence University
 Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Madison, Inc.
Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Provides gene transfer technologies to the pharmaceutical industry | Health Technology |
Unidym, Inc.
 Unidym, Inc. Electronic Production EquipmentElectronic Technology Develops and manufactures carbon nanotubes | Electronic Technology |
Benet Group LLC
 Benet Group LLC Financial ConglomeratesFinance Private equity firm | Finance |
Galway Partners LLC
Galway Partners LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
Ablaris Therapeutics, Inc. | |
Tego Biosciences Corp. | |
Arrowhead Madison, Inc. | |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Christopher Anzalone
